Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Dec 12;16(12):e75582.
doi: 10.7759/cureus.75582. eCollection 2024 Dec.

Carpal Tunnel Syndrome as a Potential Indicator of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis

Mohamed A Elghouneimy  1 , Nagham Bushara  2 , Omar A Abdelwahab  3 , Ayman A Makableh  4 , Doaa M Alnabwy  3 , Rehab A Diab  5
Affiliations
Review

Carpal Tunnel Syndrome as a Potential Indicator of Cardiac Amyloidosis: A Systematic Review and Meta-Analysis

Mohamed A Elghouneimy et al. Cureus. .

Abstract

Carpal tunnel syndrome (CTS) and cardiac amyloidosis (CA) are seemingly disparate medical conditions but may be linked. CTS can be a sign of early CA, and CA can be a hidden cause of heart failure. Therefore, in this systematic review and meta-analysis, we aim to investigate the expected correlation between the occurrence of CTS and CA. A comprehensive search was conducted across multiple databases, including PubMed, Web of Science, Scopus, and Cochrane Library, to get relevant studies previously published before June 2023. No language restrictions were applied. Randomized clinical trials and observational studies have been included to investigate the proportion of patients reporting CA among patients with an established diagnosis of CA, and also the incidence of patients who have CTS among patients with CA has been investigated with a pooled estimation of the expected time from the diagnosis of CTS till the development of CA. Studies that did not report data on CTS or CA or lacked sufficient details were excluded. Meta-analysis of data for each outcome was performed using R version R.4.3.2 software (R Foundation for Statistical Computing, Vienna, Austria) using the Meta package. Heterogeneity across studies was assessed using the I² statistic. A meta-analysis of 15 studies, including 1416 patients, evaluated the relationship between CTS and CA. Among these, 495 patients with CTS were assessed for the presence of CA, and 915 patients with CA were evaluated for the presence of CTS. The pooled meta-analysis of eight studies, which included 915 patients with CA, revealed that 38% (95% CI: 35%-41%) had a history of CTS. Conversely, the proportion of patients with CTS who developed CA was 13% (95% CI: 4%-35%). The pooled mean time from CTS to the development of CA, based on 639 patients across four studies, was 6.02 years (95% CI: 3.76-8.36). Significant heterogeneity was noted for some outcomes (e.g., proportion of CA in patients with CTS: I²=93%), likely influenced by variations in study populations, age distributions, and diagnostic criteria. Our review of the literature suggests that there may be a link between CTS and CA. However, more research is needed to confirm this link and to understand how the two conditions are related. It is important to consider the possibility of CA in patients with CTS, as screening, early detection, and timely treatment can improve outcomes by slowing disease progression and reducing complications.

Keywords: amyloidosis; cardiac amyloidosis; carpal tunnel syndrome; meta-analysis; neuropathy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. PRISMA flow diagram
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analysis
Figure 2
Figure 2. Forest plot illustrating the proportion of CA in patients with CTS
CTS: carpal tunnel syndrome; CA: cardiac amyloidosis
Figure 3
Figure 3. Forest plot illustrating the proportion of history of CTS in population with CA
CTS: carpal tunnel syndrome; CA: cardiac amyloidosis
Figure 4
Figure 4. Forest Plot illustrating the proportion of history of CTS in the population with CA
CTS: carpal tunnel syndrome; CA: cardiac amyloidosis
Figure 5
Figure 5. Forest plot for the time from CTS till the development of CA
CTS: carpal tunnel syndrome; CA: cardiac amyloidosis
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sevy JO, Sina RE, Varacallo M. Treasure Island (FL): StatPearls Publishing; 2024. Carpal Tunnel Syndrome. - PubMed
    1. Carpal tunnel syndrome: a review of literature. Genova A, Dix O, Saefan A, Thakur M, Hassan A. Cureus. 2020;12:0. - PMC - PubMed
    1. Shams P, Ahmed I. Treasure Island (FL): StatPearls Publishing; 2024. Cardiac Amyloidosis. - PubMed
    1. Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment. Siddiqi OK, Ruberg FL. Trends Cardiovasc Med. 2018;28:10–21. - PMC - PubMed
    1. The prevalence and management of systemic amyloidosis in Western countries. Nienhuis HL, Bijzet J, Hazenberg BP. Kidney Dis (Basel) 2016;2:10–19. - PMC - PubMed

LinkOut - more resources